Carmat S.A. (CKMTF) Stock
Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Carmat S.A.
Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the globe. The company was established in 2008 and operates from its primary base in Vélizy-Villacoublay, France.
Carmat S.A. is headquartered in FR.
Carmat S.A. (CKMTF) stock trades at $12.75 with a market capitalization of $85.19M. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of -0.04, price-to-sales of 0.91. Over the past 52 weeks the stock has ranged between $12.75 and $12.75, and currently trades at its 52-week high.
On profitability, Carmat S.A. generates a return on equity (ROE) of 106.81% — well above the market average, a sign of a high-quality business, return on capital employed of -210.64%, an operating margin of -702.86%, a net profit margin of -734.29%.
Official website: www.carmatsa.com